{
    "2021-06-18": [
        [
            {
                "time": "2022-07-15",
                "original_text": "Danaher's (DHR) Aldevron Buyout to Aid Genomic Medicine",
                "features": {
                    "keywords": [
                        "Danaher",
                        "Aldevron",
                        "buyout",
                        "genomic medicine"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2022-07-15",
                "original_text": "The Zacks Analyst Blog Highlights: Target, NVIDIA, The Sherwin-Williams Co, Danaher Corp and FedEx",
                "features": {
                    "keywords": [
                        "Zacks",
                        "analyst blog",
                        "Target",
                        "NVIDIA",
                        "Sherwin-Williams",
                        "Danaher",
                        "FedEx"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "retail",
                        "technology",
                        "industrial goods",
                        "healthcare",
                        "logistics"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-07-15",
                "original_text": "Danaher (DHR) Moves 5% Higher: Will This Strength Last?",
                "features": {
                    "keywords": [
                        "Danaher",
                        "moves higher",
                        "strength"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2022-07-15",
                "original_text": "Danaher Snaps up Aldevron for $9.6B; Shares Spike 5%",
                "features": {
                    "keywords": [
                        "Danaher",
                        "Aldevron",
                        "acquisition",
                        "shares spike"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}